SCHEMBL8022305

SCHEMBL8022305

C=C1CCN(C)C(c2cccc(OC)c2)C1(C)C

nearest known ligand 0.52

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.52
DRD2 P14416 2/20 0.45
CHRNB4 P30926 1/20 0.43
CHRNA3 P32297 1/20 0.43
DDB1 Q16531 1/20 0.42
CRBN Q96SW2 1/20 0.42
HTR2C P28335 4/20 0.41
KDM1A O60341 1/20 0.40
RCOR1 Q9UKL0 1/20 0.40
HTR2A P28223 2/20 0.40
HTR2B P41595 2/20 0.40
GID4 Q8IVV7 1/20 0.39
CHRNA7 P36544 1/20 0.39
SIGMAR1 Q99720 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27463785 0.99 HSD11B1 (0.51) HSD11B1DRD2CHRNB4CHRNA3DDB1
Cadaverine Tartrate SCHEMBL8034056 0.76 HSD11B1 (0.48) HSD11B1DRD2DDB1CRBN
SCHEMBL7103180 0.74 HSD11B1 (0.68) HSD11B1DRD2DDB1CRBNHTR2C
SCHEMBL13162095 0.69 CHRNB4 (0.62) DRD2CHRNB4CHRNA3CHRNA7
SCHEMBL13452591 0.68 CHRNA7 (0.56) DRD2CHRNB4CHRNA3CHRNA7
SCHEMBL28829972 0.67 KDM1A (0.60) HSD11B1DRD2DDB1CRBNHTR2C
SCHEMBL14613763 0.67 HTR2C (0.64) DRD2DDB1CRBNHTR2CHTR2A
SCHEMBL4404670 0.67 DRD2 (0.71) DRD2HTR2CGID4
SCHEMBL13452486 0.67 CHRNA7 (0.54) DRD2CHRNB4CHRNA3CHRNA7
SCHEMBL27881141 0.67 DRD2 (0.48) DRD2CHRNB4CHRNA3HTR2CCHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6140502-A Heat-based process for the re-racemisation of a (-)-2-phenylmethyl-3,3-dimethyl-piperidin-4-on derivative BOEHRINGER INGELHEIM KG (DE) 2000-10-31 US disclosed
US-6136980-A Method of preparing norbenzomorphane as an intermediate in the preparation of pharmaceutically useful benzomorphane derivatives, in particular (-)-(1R,5S,2\"R)-3'-hydroxy-2-(2-methoxypropyl)-5,9,9-trimethyl-6,7-benzo morphane BOEHRINGER INGELHEIM KG (DE) 2000-10-24 US disclosed
US-6054604-A Method of preparing norbenzomorphane as an intermediate BOEHRINGER INGELHEIM KG (DE) 2000-04-25 US disclosed
US-5945535-A Method of preparing norbenzomorphanes BOEHRINGER INGELHEIM KG (DE) 1999-08-31 US disclosed